1. Choi, Jae Eun, Qiao, Yuanyuan, Kryczek, Ilona, Zou, Weiping, Chinnaiyan, Arul M. 2024. PIKfyve, expressed by CD11c-positive cells, controls tumor immunity. In Nature communications, 15, 5487. doi:10.1038/s41467-024-48931-9. https://pubmed.ncbi.nlm.nih.gov/38942798/
2. Cheng, Caleb, Hu, Jing, Mannan, Rahul, Lyssiotis, Costas A, Chinnaiyan, Arul M. 2024. Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.03.18.585580. https://pubmed.ncbi.nlm.nih.gov/38562800/
3. Bao, Yi, Qiao, Yuanyuan, Choi, Jae Eun, Zou, Weiping, Chinnaiyan, Arul M. 2023. Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2314416120. doi:10.1073/pnas.2314416120. https://pubmed.ncbi.nlm.nih.gov/38011559/
4. Choi, Jae Eun, Qiao, Yuanyuan, Kryczek, Ilona, Zou, Weiping, Chinnaiyan, Arul M. 2024. PIKfyve controls dendritic cell function and tumor immunity. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.02.28.582543. https://pubmed.ncbi.nlm.nih.gov/38464258/
5. Roy, Ajit, Chakraborty, Arup R, DePamphilis, Melvin L. 2024. PIKFYVE inhibitors trigger interleukin-24-dependent cell death of autophagy-dependent melanoma. In Molecular oncology, 18, 988-1011. doi:10.1002/1878-0261.13607. https://pubmed.ncbi.nlm.nih.gov/38414326/
6. Mei, Shaoyi, Wu, Yi, Wang, Yan, Yu, Tao, Zhao, Jun. 2022. Disruption of PIKFYVE causes congenital cataract in human and zebrafish. In eLife, 11, . doi:10.7554/eLife.71256. https://pubmed.ncbi.nlm.nih.gov/35023829/
7. Wang, Xu, Ni, Jiahui, You, Yan, Shen, Weixing, Shen, Xiaoyan. 2021. SNX10-mediated LPS sensing causes intestinal barrier dysfunction via a caspase-5-dependent signaling cascade. In The EMBO journal, 40, e108080. doi:10.15252/embj.2021108080. https://pubmed.ncbi.nlm.nih.gov/34747049/
智鼠故事 
